SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is seeing intense retail and institutional focus as investors speculate on a short squeeze fueled by high short interest and anticipation of key trial results. The community is heavily divided, with long-term holders dismissing bearish concerns about trial design and the efficacy of Best Available Therapy as 'FUD' while bulls aggressively anticipate a potential buyout or major data-driven price move.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing significant volatility and trading volume as community members debate whether the asset is primed for a major short squeeze or trapped in a cycle of pump-and-dump behavior. Many are actively tracking support levels and liquidity shifts, while others express caution due to historical price swings and recent exchange delisting concerns.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is experiencing significant price volatility as the semiconductor sector grapples with broader tech market fluctuations and shifting investor sentiment toward AI hardware. The community is actively debating the stock's valuation, with many traders monitoring its ability to maintain key support levels amidst intense algorithmic trading activity and mixed macroeconomic signals.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing a strong recovery fueled by massive institutional accumulation and high trading volume during index rebalancing, further bolstered by reports of Michael Burry initiating bullish long-dated options positions. The community is actively debating whether this movement represents a sustainable trend reversal driven by fundamentally undervalued quality, or merely a short-term relief rally amidst broader sector rotation.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as investors weigh its pivot toward AI infrastructure and potential long-term fiber value against persistent sector concerns regarding competition from satellite-based connectivity. The market remains focused on the company's recent exclusion from the Dow Jones Industrial Average and ongoing adjustments to its debt structure as it navigates a challenging telecom landscape.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is seeing heightened community discussion as traders debate the stock's potential for a breakout following the elimination of the Pattern Day Trader (PDT) rule, which many believe will significantly boost trading volumes and revenue. While some investors are expressing frustration over the stock's struggle to hold key price levels compared to sector peers, others are highlighting institutional accumulation and strong underlying cash reserves as signs of a long-term undervalued opportunity.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently trending as investors focus on its critical role in providing on-site, behind-the-meter power solutions to solve the grid bottleneck caused by rapidly expanding AI data centers. Community discussion is split between excitement over the company's long-term utility in the AI infrastructure buildout and intense debate regarding its valuation, volatility, and technical price movements following index rebalancing.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is currently experiencing intense institutional rotation as investors weigh its aggressive share buyback program and AI-driven growth against broader sector sentiment shifts. While the stock has faced a historic streak of negative sessions, community discourse remains sharply divided between those viewing the current valuation as a generational entry point for long-term AI monetization and skeptics pointing to persistent bearish momentum.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors debate its transition from Bitcoin mining to a high-beta AI infrastructure play, driven by excitement over NVIDIA and Microsoft partnerships alongside intense scrutiny of recent management marketing expenditures. While bulls highlight the company's massive power pipeline and secular AI compute growth as a long-term catalyst, bears are vocal about ongoing dilution risks and the lack of immediate, large-scale hyperscaler deal announcements.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is trending as investors rally behind its role as a governance token for the decentralized Re Protocol, which aims to bring the global reinsurance market on-chain. The community is actively discussing its recent listings on major exchanges and its potential for growth, with many focused on its utility and limited circulating supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MRNA Stock Rallies Over 40% In June: Moderna Bets Its Future On Cancer, Autoimmune Disease And AI-Powered mRNA 

Equity

Cancer was a key focus, with programs targeting solid tumors, Lynch syndrome, melanoma, and non-small cell lung cancer.

Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week?

Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business outlook. 


Stocks making the biggest moves midday: Moderna, ON Semiconductor, Rocket Lab, Eli Lilly, Sandisk & more

Here are the companies making headlines in midday trading...

Moderna (MRNA) Rises As Market Takes a Dip: Key Facts

Moderna (MRNA) closed at $61 in the latest trading session, marking a +2.79% move from the prior day.

Should You Buy Moderna Before Aug. 5?

Key PointsInvestors flocked to Moderna during early pandemic days as its coronavirus vaccine delivered blockbuster revenue...

Moderna Has Some Key Approvals Ahead. Is the Stock a Buy?

Key PointsModera grew revenue by 260% year over year in the first quarter...

MRNA Up as Influenza Vaccine Wins Unanimous FDA Advisory Panel Backing

Moderna stock gains 3.5% after FDA advisory panel votes 9-0 that mFlusiva's benefits outweigh risks in influenza prevention in older adults, ahead of an Aug. 5 decision.

MRNA Stock Clocks Best Week In Over 4 Years On FDA Advisory Committee Endorsement For Flu Vaccine

Jefferies noted that FDA decisions aligned with advisory committee recommendations 84% of the time between 2020 and 2025.


Bulls Pile Into Moderna As FDA Decision Nears, Ignites 60% Surge In This ETF

Moderna shares have surged nearly 30% in five days, ahead of a key FDA advisory vote on its flu vaccine, lifting the leveraged MRNX ETF more than 60%.read more...

MRNA Stock Jumps as FDA Briefing Docs Ease Flu Shot Approval Concerns

Moderna jumps after FDA briefing documents on mFlusiva appear more constructive than expected ahead of a key advisory panel review.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

Investors are hyper-focused on the company's shift toward oncology and T-cell therapies following positive data releases from Science Day.

Massive call buying activity and institutional accumulation are fueling volatile upward price momentum.

Anticipation builds around upcoming FDA decisions for flu vaccines and late-stage clinical readouts in the second half of the year.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$2.06	--	--	N/A
Q1 '26	-$4.45	-$3.40	23.53%	BEAT
Q4 '25	-$2.54	-$2.11	17.07%	BEAT
Q3 '25	-$2.12	-$0.51	75.96%	BEAT
Q2 '25	-$2.96	-$2.13	28.11%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

MRNAModerna Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest MRNA News